# How does GHRP-2 affect growth hormone release in elderly men?

Canonical source: https://retacompare.com/research/how-does-ghrp-2-affect-growth-hormone-release-in-elderly-men

Peptide Longevity Q&A · 2000-12-01


    Research indicates that GHRP-2 significantly enhances growth hormone (GH) release in elderly men, particularly when combined with acipimox, which reduces circulating free fatty acids (FFAs). This suggests that GHRP-2 may help reverse age-related declines in GH secretion.


What the research shows

The study evaluated the effects of GH-releasing peptide 2 (GHRP-2) on growth hormone release in nine healthy elderly men. Participants received GHRP-2 with or without pretreatment with acipimox, an antilipolytic drug that reduces circulating FFAs. The researchers measured the area under the curve (AUC) of GH responses after administration of GHRP-2 and compared these responses with those following the administration of growth hormone-releasing hormone (GHRH). The findings revealed that the GH response after GHRP-2 alone was significantly higher than that after GHRH alone. Furthermore, acipimox pretreatment not only reduced FFAs but also enhanced the GH release response to both GHRP-2 and GHRH.


Why it matters for longevity

The reduction of circulating FFAs through acipimox led to a notable increase in GH release in elderly men. This finding is significant because aging is often associated with decreased GH levels, which can impact various physiological functions, including metabolism, muscle mass maintenance, and overall health. By enhancing GH release, GHRP-2 may contribute to mitigating some of the negative effects of aging, potentially improving healthspan and longevity. The ability to stimulate GH release in older adults suggests that interventions targeting GH secretion could be beneficial for age-related conditions.


Key findings at a glance

GHRP-2 significantly increased GH release compared to GHRH alone.

The GH response after GHRP-2 was 4.8 times higher than that of GHRH.

Acipimox reduced FFAs from 607 micromol/L to 180 micromol/L.

GH AUC after GHRP-2 with acipimox was significantly increased.

Basal FFAs negatively correlated with GH responses.


How GHRP-2 works (background)

GHRP-2 is a synthetic peptide that stimulates the secretion of growth hormone from the pituitary gland. It acts by binding to specific receptors that promote the release of GH, which plays a crucial role in various metabolic processes. The peptide's effectiveness can be influenced by the levels of circulating FFAs; higher levels of FFAs are associated with reduced GH release. The study demonstrated that lowering FFAs through acipimox enhances the GH-releasing capacity of GHRP-2, indicating a potential mechanism for improving GH levels in aging populations.


Safety, caveats, and what we don't yet know

While the study provides valuable insights into the effects of GHRP-2 on GH release, it is important to note that the research was conducted on a small sample of healthy elderly men. Further studies are needed to explore the long-term effects and safety of GHRP-2 in larger and more diverse populations. Additionally, the implications of enhanced GH release for overall health and longevity require more comprehensive investigation, especially in relation to potential side effects and interactions with other metabolic processes.


Bottom line

In summary, GHRP-2 significantly enhances growth hormone release in elderly men, particularly when combined with acipimox, suggesting a potential avenue for addressing age-related declines in GH secretion.


Related questions

Can GHRP-2 improve muscle mass in older adults?

Research suggests that GHRP-2 may enhance growth hormone release, which is essential for muscle growth and maintenance. This could potentially help older adults retain muscle mass, but further studies are needed to confirm these effects.

Does GHRP-2 have any effects on metabolism in aging populations?

GHRP-2's ability to stimulate growth hormone release may positively impact metabolism, particularly in older adults. However, more research is necessary to fully understand its metabolic effects and implications for aging.

What are the potential side effects of GHRP-2?

While the study did not report on side effects, potential risks associated with GHRP-2 use can include hormonal imbalances and other metabolic changes. More extensive research is needed to identify and evaluate these risks.


Source: PubMed · J Clin Endocrinol Metab · published 2000-12-01.

## Sources

- PubMed · J Clin Endocrinol Metab: https://pubmed.ncbi.nlm.nih.gov/11134132/